Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Edwards Lifesciences (NY: EW ) 81.02 +0.53 (+0.66%) Streaming Delayed Price Updated: 12:52 PM EDT, Mar 29, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Edwards Lifesciences < Previous 1 2 3 4 5 6 7 Next > Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 Today 11:00 EDT Via Benzinga The Latest Analyst Ratings for Edwards Lifesciences Today 10:01 EDT Via Benzinga Looking Into Edwards Lifesciences's Recent Short Interest March 15, 2023 Via Benzinga Expert Ratings for Edwards Lifesciences March 08, 2023 Via Benzinga Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views January 31, 2023 The company expects full-year sales to grow 9%-12% in constant currency. Via Investor's Business Daily Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today January 31, 2023 Via Benzinga What 8 Analyst Ratings Have To Say About Edwards Lifesciences January 30, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 March 08, 2023 Via Benzinga Interview With David Rolfe of Wedgewood Partners February 17, 2023 Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe. Via The Motley Fool Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 4 February 04, 2023 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Jan. 30 through Feb. 3. Via Talk Markets A Preview Of Edwards Lifesciences's Earnings January 30, 2023 Via Benzinga Expert Ratings for Edwards Lifesciences November 28, 2022 Via Benzinga 15 Analysts Have This to Say About Edwards Lifesciences November 28, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 February 06, 2023 Via Benzinga Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023 February 01, 2023 Via Benzinga 2 Top Dividend Growth Stocks to Buy in February February 01, 2023 They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace. Via The Motley Fool Earnings Scheduled For January 31, 2023 January 31, 2023 Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023 January 30, 2023 Via Benzinga Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday January 30, 2023 Barclays cut the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $140 to $130. Barclays analyst Ross Sandler maintained an Overweight rating. Amazon shares fell 1.2% to $101.06 in pre-market... Via Benzinga 2 Smartest Tech Stocks to Buy in 2022 and Beyond December 20, 2022 The tech space is still bursting with opportunities for long-term investors. Via The Motley Fool Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators' December 16, 2022 Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023. Via Benzinga JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday December 06, 2022 Via Benzinga Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands November 28, 2022 Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 December 06, 2022 Via Benzinga Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It' November 03, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cerence Inc. (NASDAQ: CRNC) can fall to $13, $12 in a market like this. "If you can take that level of pain, you can absolutely buy it, because it... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022 December 02, 2022 Via Benzinga 7 Stocks to Buy at the ‘Midterm Elections’ Bottom October 31, 2022 With the market tending to react positively to midterm election cycles, now may be a time to consider certain stocks to buy. Via InvestorPlace Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93% October 31, 2022 Daiwa Capital slashed the price target on Honeywell International Inc. (NYSE: HON) from $206 to $194. Honeywell shares fell 0.6% to $203.79 in pre-market trading. Via Benzinga Weibo, XPeng, Li Auto And Other Big Losers From Friday October 31, 2022 U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday October 31, 2022 Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
